A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Hospitalized patients with schizophrenia or schizoaffective disorder
At least a 6th grade reading level
Males or females, between 18 and 70 years of age at the time of consent
Subjects must have been hospitalized for no more than 14 consecutive days immediately prior to screening
You may not be if
Psychiatric disorder other than schizophrenia or schizoaffective disorder
History of arrhythmia, heart attack, or heart failure
Clareo Health | A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients
